- Home
- AMTX vs GALT Comparison
AMTX vs GALT Comparison
Compare AMTX & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTX
- GALT
- Stock Information
- Founded
- AMTX 2005
- GALT 2000
- Country
- AMTX United States
- GALT United States
- Employees
- AMTX N/A
- GALT N/A
- Industry
- AMTX Major Chemicals
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- AMTX Industrials
- GALT Health Care
- Exchange
- AMTX Nasdaq
- GALT Nasdaq
- Market Cap
- AMTX 90.3M
- GALT 83.5M
- IPO Year
- AMTX N/A
- GALT N/A
- Fundamental
- Price
- AMTX $1.69
- GALT $1.30
- Analyst Decision
- AMTX Strong Buy
- GALT Hold
- Analyst Count
- AMTX 4
- GALT 1
- Target Price
- AMTX $13.18
- GALT N/A
- AVG Volume (30 Days)
- AMTX 1.1M
- GALT 176.3K
- Earning Date
- AMTX 05-08-2025
- GALT 05-15-2025
- Dividend Yield
- AMTX N/A
- GALT N/A
- EPS Growth
- AMTX N/A
- GALT N/A
- EPS
- AMTX N/A
- GALT N/A
- Revenue
- AMTX $237,892,000.00
- GALT N/A
- Revenue This Year
- AMTX $31.76
- GALT N/A
- Revenue Next Year
- AMTX $86.51
- GALT N/A
- P/E Ratio
- AMTX N/A
- GALT N/A
- Revenue Growth
- AMTX N/A
- GALT N/A
- 52 Week Low
- AMTX $1.22
- GALT $0.73
- 52 Week High
- AMTX $4.73
- GALT $3.17
- Technical
- Relative Strength Index (RSI)
- AMTX 53.16
- GALT 48.58
- Support Level
- AMTX $1.64
- GALT $1.22
- Resistance Level
- AMTX $1.80
- GALT $1.36
- Average True Range (ATR)
- AMTX 0.10
- GALT 0.09
- MACD
- AMTX 0.01
- GALT 0.00
- Stochastic Oscillator
- AMTX 54.02
- GALT 47.57
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.